Latest Carboplatin Stories
Tokyo, Jan 11, 2013 - (JCN Newswire) - Eisai Co., Ltd.
A new study published in The Oncologist found that genetically engineered mouse models appear to be the most accurate preclinical predictor of how cancer-fighting drugs are delivered to melanoma
Patients with the most common type of lung cancer are notoriously insensitive to chemotherapy drugs, including cisplatin.
Researchers at MIT recently revealed a new platinum compound that could eliminate cancer cells more effectively than cisplatin, a popular chemotherapy anticancer drug.